Topics

Novartis trims again with $390m drugs sale to Recordati

05:11 EDT 15 Jul 2019 | pharmaphorum

Novartis has been streamlining its business since CEO Vas Narasimhan took over, and has continued that push with the divestment of three drugs to Recordati for $390 million upfront. The Italian drugmaker is taking control of Signifor and its long-...

Original Article: Novartis trims again with $390m drugs sale to Recordati

NEXT ARTICLE

More From BioPortfolio on "Novartis trims again with $390m drugs sale to Recordati"

Quick Search

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...